A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
Clinical trial NCT00716859 · COMPLETED
Trial details
- NCT number
- NCT00716859
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-11-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.